isoxazoles has been researched along with Ischemic Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azab, AN; Boyko, M; Ferorelli, S; Kaplanski, J; Perrone, MG; Rostevanov, IS; Scilimati, A; Zlotnik, A | 1 |
| Cheng, G; Huang, G; Li, Y; Li, Z; Liu, Y; Lu, L; van Leyen, K; Xin, Y; Zhan, M; Zhao, W | 1 |
2 other study(ies) available for isoxazoles and Ischemic Stroke
| Article | Year |
|---|---|
Inhibition of cyclooxygenase-1 does not reduce mortality in post-ischemic stroke rats.
Topics: Animals; Brain; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Ischemic Stroke; Isoxazoles; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2020 |
Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Brain Infarction; Cerebrovascular Circulation; Cytokines; Drug Therapy, Combination; Glucose; Hypoxia, Brain; Intracranial Embolism; Ischemic Stroke; Isoxazoles; JNK Mitogen-Activated Protein Kinases; Lipoxygenase Inhibitors; Male; Microglia; Naphthalenes; Rats; Rats, Sprague-Dawley; Reperfusion; Tissue Plasminogen Activator | 2021 |